Core Viewpoint - Xierman Technology aims to provide cost-effective, high-precision, and rapid testing analytical instruments and methods for China's biopharmaceutical and food enterprises, thereby reducing daily operational costs [2]. Group 1: Company Overview - Xierman Technology focuses on the research and production of online dissolved oxygen electrodes, pH electrodes, cell culture biochemical analyzers, biosensors, and ion concentration analyzers [2]. - The company officially opened on September 27, 2025, in Wuxi, with industry guests, partners, and company leaders attending the ceremony [2][3][4]. Group 2: Industry Context - The biopharmaceutical industry is experiencing unprecedented development opportunities, making the establishment of Xierman in Wuxi timely and promising [6]. - The company addresses the challenge of foreign monopolization of core technologies in high-end biological equipment [8]. Group 3: Product and Technology - All products have independent intellectual property rights, with mass production achieved in four major product categories, demonstrating technology levels comparable to or exceeding advanced domestic and international products [8]. - The newly launched AMF-101 integrated online detection bioreactor utilizes sterile microfluidic technology for automatic biochemical detection of culture solutions and features an intelligent closed-loop control system, showcasing the company's technological innovation [12][13]. Group 4: Service Commitment - Xierman is committed to creating a "concierge" service system, covering laboratory design, equipment installation, personnel training, and post-maintenance, truly implementing a customer-centric philosophy [13]. Group 5: Future Aspirations - The opening of Xierman marks the beginning of a new journey, with the company steadily moving towards the goal of becoming a world-class manufacturer of biological culture solutions [15].